Glatiramer acetate for multiple sclerosis
35 results
1 - 35
Glatiramer acetate for multiple sclerosis 
Glatiramer acetate for multiple sclerosis New search for studies and content updated (no change to conclusions)- Interferons‐beta versus glatiramer acetate for relapsing‐remitting multiple sclerosis New search for studies and content updated (no change to conclusions)
- Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis Edited (no change to conclusions)
- Recombinant interferon beta for delaying conversion of the first demyelinating event to multiple sclerosis
- Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis: Cochrane systematic review
- Natalizumab for relapsing remitting multiple sclerosis
- Immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis: a network meta‐analysis New
- Alemtuzumab for multiple sclerosis New
- Rituximab for people with multiple sclerosis New
- Alemtuzumab for multiple sclerosis
- Azathioprine for multiple sclerosis Edited (no change to conclusions)
- Sodium channel blockers for neuroprotection in multiple sclerosis New
- Treatment with disease‐modifying drugs for people with a first clinical attack suggestive of multiple sclerosis New
- Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis (RRMS): a network meta-analysis
- Laquinimod for multiple sclerosis: Cochrane systematic review
- Rituximab for relapsing-remitting multiple sclerosis: Cochrane systematic review
- Natalizumab for relapsing remitting multiple sclerosis: Cochrane systematic review
- Dimethyl fumarate for multiple sclerosis: Cochrane systematic review
- Teriflunomide for multiple sclerosis New search for studies and content updated (conclusions changed)
- Multiple sclerosis (MS)